Concepedia
Statistics
Publications
46
Citations
2.5K
H-Index
28
Active since
1973
Affiliations
AstraZeneca (United Kingdom)(Current)
Leeds Dental Hospital
University of Leeds
Pfizer (United Kingdom)
M G Collis is an author at AstraZeneca (United Kingdom) specializing in pharmacology, medicine, and pharmacodynamics.
Publications per year
1973–2014
The in vitro pharmacology of ZM 241385, a potent, non‐xanthine, A<sub>2a</sub>selective adenosine receptor antagonist
Simon M. Poucher, J R Keddie, Parminder Singh et al. · British Journal of Pharmacology · 1995 · 364 citations · Full text
Medicine, Pharmacology, General Pharmacology +8
Inducible expression of human endoglin during inflammation and wound healing in vivo
Evelyn Torsney, Richard Charlton, Dinah V. Parums et al. · Inflammation Research · 2002 · 154 citations
Veterinary Medicine, Cell Biology, Immunology +16
Vascular reactivity of isolated perfused kidneys from male and female spontaneously hypertensive rats.
M G Collis, Paul M. Vanhoutte · Circulation Research · 1977 · 138 citations · Full text
Medicine, Nephrology, Physiology +13
Interaction of angiotensin-converting enzyme inhibitors with the function of the sympathetic nervous system
D.P. Clough, M G Collis, James Conway et al. · The American Journal of Cardiology · 1982 · 132 citations
Medicine, Pharmacology, Pharmacotherapy +14
Adenosine relaxes the aorta by interacting with an A2 receptor and an intracellular site
M G Collis, Christine M. Brown · European Journal of Pharmacology · 1983 · 131 citations
Life Sciences, Pharmacology, Physiology +14
1–5 of 46